PHARMACY

Rite Aid gets fit with BL Body

BY Michael Johnsen

CAMP HILL, Pa. — Rite Aid on Tuesday announced its partnership with BL Body, a collection of shape wear available exclusively in Rite Aid stores, on a sweepstakes with a first prize trip for two to the location of the reality program “The Biggest Loser.”

Rite Aid is taking sweepstake entries through Jan. 22 for the $4,000-grand prize. Second prize is a year’s membership for two to the Biggest Loser Club online weight-loss program, a $479 value.

The sweepstakes is being promoted with in-store radio and a national radio tour featuring Ashley Johnston, the runner-up to season nine who set a show all-time record for most weight loss by a woman. Johnston also is a spokeswoman for the BL Body collection of shape wear inspired by the show.

Rite Aid already has an established weight-loss heritage in the California market through its retail-clinic partnership with weight-loss clinic Lindora.

The chain provides a 12-page informational guide in stores or online at RiteAid.com packed with weight-loss tips, techniques and topics, including how to fight childhood obesity, the importance of counting calories instead of just carbohydrates or fat and how to exercise on a budget.

Rite Aid customers also can access the Rite Weight program at RiteAid.com/RiteWeightPlan. That program, created by Lindora, aims to help patients lose up to 10% of their body weight in 10 weeks with free online seminars, weight-tracking tools and daily support e-mails.

For members of its free Wellness+ customer rewards program, Rite Aid is offering discounts and rebates on healthy weight products purchased through Jan. 22. Specials include buy-one/get-one-free offers on vitamins and supplements, meal replacements and fat burners.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

Par launches generic Rhythmol SR

BY Alaric DeArment

WOODCLIFF LAKE, N.J. — Generic drug maker Par Pharmaceutical has begun shipping its version of a treatment for heart rhythm problems, the company said Monday.

Par announced the shipment of propafenone SR capsules, a treatment for atrial fibrillation in patients without structural heart disease.

The drug is a generic version of GlaxoSmithKline’s Rhythmol SR, which has annual sales of around $121 million, according to IMS Health.

As the first company to file for approval of a generic version of the drug, Par has 180 days in which to market its version in direct competition with GlaxoSmithKline’s under the terms of the Hatch-Waxman Act of 1984.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

Endo’s Fortesta receives FDA approval

BY Alaric DeArment

CHADDS FORD, Pa. — The Food and Drug Administration has approved a topical testosterone replacement therapy made by Endo Pharmaceuticals, Endo said last week.

The drug maker announced on Dec. 29 the approval of Fortesta (testosterone) gel, a treatment for men with low testosterone, which affects nearly 14 million men in the United States.

Endo said it planned to introduce Fortesta in the United States early this year.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?